What is Olodaterol-Tiotropium?

Category: Prescription Drugs

Most popular types: Stiolto Respimat

false

Olodaterol is a long-acting bronchodialator. This agent is still in clinical trials being evaluated as a once-daily treatment for chronic obstructive pulmonary disease (COPD) alone as a stand-alone product and also in combination with tiotropium, another once-daily bronchodilator.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
1
None
2

Commonly reported side effects and conditions associated with Olodaterol-Tiotropium

Side effect Patients
Dry mouth 1

Dosages

Based on patients currently taking Olodaterol-Tiotropium

Dosage Patients
2 mcg daily 1
2.5-2.5 mcg/puff daily 1
2 x 2.5-2.5 mcg/puff twice daily 1

Duration

Currently taking Olodaterol-Tiotropium

Duration Patients
1 - 2 years 2
2 - 5 years 1
Adherence
Adherence Evaluations
Always 3
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 1
A little hard to take 0
Not at all hard to take 2
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 0
$50-99 0
$25-49 0
< $25 0
Not specified 2

What people switch to and from

Patients started taking Olodaterol-Tiotropium after stopping:

Treatment Patients
Budesonide-Formoterol (Symbicort) 1
Fluticasone (Flovent HFA) 1
Fluticasone furoate-Vilanterol (Breo Ellipta) 1
Formoterol (Foradil Aerolizer) 1
Tiotropium inhaler (Spiriva HandiHaler) 1

Patients stopped taking Olodaterol-Tiotropium and switched to:

Treatment Patients
Fluticasone (Flovent HFA) 1
Last updated:
There are no evaluations for Olodaterol-Tiotropium.